Navigation Links
New Vaccine to Combat Pneumococcal Diseases

Every year around the world nearly one million children under the age of five lose their lives to pneumonia and other pneumococcal diseases//.

Considering the fact that these deaths are preventable, WHO has recommended the inclusion of the 7-valet vaccine that addresses seven different strains of pneumococcal diseases in the immunization programs of developing countries.

Pneumococcal diseases, which affect the lungs, brain and the blood stream, can affect people of all age groups. Children, however, are more vulnerable with the highest risk period being the first 24 months of life.

Although the vaccine is to be introduced in the routine childhood immunization programs, it can also be administered to previously unvaccinated children in the age group of 12-24 months and to high risk children between the age of two to five years by a single catch up dose.

The vaccine is currently available in 74 countries and is part of the immunization programs of 16 of them. However, in India, the vaccine is yet to be officially introduced.

"Broad adoption of the WHO's recommendation has the potential to save millions of innocent lives around the world," said Ranga Iyer, managing director of Wyeth Limited, the pharmaceutical company whose product the vaccine is.

Although the vaccine was launched in India in June last year, Iyer said they were waiting for the green signal by the Indian government and the Indian Academy of Pediatricians (IAP) for it to be included in the national immunization program.

With the World Health Day just two days away, this is one of the steps WHO has taken to attain its goal this year - to achieve international health security.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... ... ... Millennium”: a gripping take on how the author used personal experience to strengthen the ... do not affect daily choices. It shows how to act like the heirs of ... chosen. “How to Live in the Millennium” is the creation of published author, Gina ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sonflower Submission”: a ... nature to the inevitable destinations of negativity, complaining and the need to always be ... take effect in order for a lesson in stress-less living to be learned. ...
(Date:9/25/2017)... ... September 26, 2017 , ... Your World Insurance Services, a long-time ... began fulfilling a life-long wish of owner Stacy Boyle to give back to the ... help when I was in high school,” said Ms. Boyle. “My father passed away ...
(Date:9/25/2017)... ... September 25, 2017 , ... SyncDog, ... release of SentinelSecure™, version 3.0, will be available in a managed cloud services ... of SentinelSecure™ comes with several new enhancements including support for caller ID and ...
(Date:9/25/2017)... ... September 25, 2017 , ... The Byron Eaton Agency, a Birmingham based ... region, is organizing a local charity drive to send money and support to families ... of water have fallen on Houston as a result of Hurricane Harvey, raising water ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), the ... and tissue hypothermic storage and cryopreservation freeze ... and CEO, will be presenting at two investment conferences in ... th Annual Global Investment Conference on Tuesday, September 12th, ... conference is being held at the New York Palace Hotel ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of ... successfully concluded its meeting with the U.S. Food and ... insulin formulation. At ... regulatory pathway for submission of ORMD-0801, would be a ...
Breaking Medicine Technology: